References
- Jensen TS , BaronR, HaanpaaM et al. A new definition of neuropathic pain. Pain 152(10) , 2204–2205 (2011).
- Bennett MI , SmithBH, TorranceN, LeeAJ. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain122(3) , 289–294 (2006).
- Breivik H , CollettB, VentafriddaV, CohenR, GallacherD. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur. J. Pain10(4) , 287–333 (2006).
- Bouhassira D , Lanteri-MinetM, AttalN, LaurentB, TouboulC. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain136(3) , 380–387 (2008).
- Torrance N , SmithBH, BennettMI, LeeAJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J. Pain7(4) , 281–289 (2006).
- van der Windt DA , DunnKM, Spies-DorgeloMN, MallenCD, BlankensteinAH, StalmanWA. Impact of physical symptoms on perceived health in the community. J. Psychosom. Res.64(3) , 265–274 (2008).
- Freynhagen R , BaronR, GockelU, TölleTR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr. Med. Res. Opin.22(10) , 1911–1920 (2006).
- Davies M , BrophyS, WilliamsR, TaylorA. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care29(7) , 1518–1522 (2006).
- Bennett MI , RaymentC, HjermstadM, AassN, CaraceniA, KaasaS. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain153(2) , 359–365 (2012).
- Bowsher D . The lifetime occurrence of herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population. Eur. J. Pain3(4) , 335–342 (1999).
- Choo PW , GalilK, DonahueJG, WalkerAM, SpiegelmanD, PlattR. Risk factors for postherpetic neuralgia. Arch. Intern. Med.157(11) , 1217–1224 (1997).
- Johansen A , RomundstadL, NielsenCS, SchirmerH, StubhaugA. Persistent postsurgical pain in a general population: prevalence and predictors in the Tromso study. Pain153(7) , 1390–1396 (2012).
- Hochman JR , GaglieseL, DavisAM, HawkerGA. Neuropathic pain symptoms in a community knee OA cohort. Osteoarthritis Cartilage19(6) , 647–654 (2011).
- Peng P , ChoiniereM, DionD et al. Challenges in accessing multidisciplinary pain treatment facilities in Canada. Can. J. Anaesth. 54(12) , 977–984 (2007).
- Jensen MP , ChodroffMJ, DworkinRH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology68(15) , 1178–1182 (2007).
- Doth AH , HanssonPT, JensenMP, TaylorRS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain149(2) , 338–344 (2010).
- Smith BH , TorranceN, BennettMI, LeeAJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin. J. Pain23(2) , 143–149 (2007).
- Attal N , Lanteri-MinetM, LaurentB, FermanianJ, BouhassiraD. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain152(12) , 2836–2843 (2011).
- Dworkin RH , PanaritesCJ, ArmstrongEP, MaloneDC, PhamSV. Healthcare utilization in people with postherpetic neuralgia and painful diabetic peripheral neuropathy. J. Am. Geriatr. Soc.59(5) , 827–836 (2011).
- O‘Connor AB . Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics27(2) , 95–112 (2009).
- Smith BH , TorranceN. Epidemiology of neuropathic pain and its impact on quality of life. Curr. Pain Headache Rep.16(3) , 191–198 (2012).
- Tesfaye S , ChaturvediN, EatonSE et al. Vascular risk factors and diabetic neuropathy. N. Engl. J. Med. 352(4) , 341–350 (2005).
- Jensen TS , BackonjaMM, Hernandez Jimenez S, Tesfaye S, Valensi P, Ziegler D. New perspectives on the management of diabetic peripheral neuropathic pain. Diab. Vasc. Dis. Res.3(2) , 108–119 (2006).
- Jung BF , JohnsonRW, GriffinDR, DworkinRH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology62(9) , 1545–1551 (2004).
- Kehlet H , JensenTS, WoolfCJ. Persistent postsurgical pain: risk factors and prevention. Lancet367(9522) , 1618–1625 (2006).
- Bennett MI , AttalN, BackonjaMM et al. Using screening tools to identify neuropathic pain. Pain 127(3) , 199–203 (2007).
- Haanpaa ML , BackonjaMM, BennettMI et al. Assessment of neuropathic pain in primary care. Am. J. Med. 122(Suppl. 10) , S13–S21 (2009).
- Attal N , CruccuG, BaronR et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. 17(9) , 1113–e88 (2010).
- Finnerup NB , SindrupSH, JensenTS. The evidence for pharmacological treatment of neuropathic pain. Pain150(3) , 573–581 (2010).
- NICE Clinical Guideline 96: pharmacological management of neuropathic pain in non-specialist settings. National Institute of Health and Clinical Excellence. London, UK, March 2010.
- Daniel HC , NarewskaJ, SerpellM, HoggartB, JohnsonR, RiceAS. Comparison of psychological and physical function in neuropathic pain and nociceptive pain: implications for cognitive behavioral pain management programs. Eur. J. Pain12(6) , 731–741 (2008).
- Turk DC , AudetteJ, LevyRM, MackeySC, StanosS. Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain. Mayo Clin. Proc.85(Suppl. 3) , S42–S50 (2010).
- Dobscha SK , CorsonK, PerrinNA et al. Collaborative care for chronic pain in primary care: a cluster randomized trial. JAMA 301(12) , 1242–1252 (2009).
- Lamb SE , HansenZ, LallR et al. Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis. Lancet 375(9718) , 916–923 (2010).
- Pittler MH , ErnstE. Complementary therapies for neuropathic and neuralgic pain: systematic review. Clin. J. Pain24(8) , 731–733 (2008).
- Ellis RJ , ToperoffW, VaidaF et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 34(3) , 672–680 (2009).
- Iskedjian M , BerezaB, GordonA, PiwkoC, EinarsonTR. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr. Med. Res. Opin.23(1) , 17–24 (2007).
- Ware MA , WangT, ShapiroS et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 182(14) , E694–E701 (2010).
- Brunelli B , GorsonKC. The use of complementary and alternative medicines by patients with peripheral neuropathy. J. Neurol. Sci.218(1–2) , 59–66 (2004).
- Heutink M , PostMW, WollaarsMM, van Asbeck FW. Chronic spinal cord injury pain: pharmacological and non-pharmacological treatments and treatment effectiveness. Disabil. Rehabil.33(5) , 433–440 (2011).
- Williams AC , JohnsonM. Persistent pain: not a medically unexplained symptom. Br. J. Gen. Pract.61(591) , 638–639 (2011).
- Torrance N , SmithBH, WatsonMC, BennettMI. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam. Pract.24(5) , 481–485 (2007).
- Dworkin RH , PanaritesCJ, ArmstrongEP, MaloneDC, PhamSV. Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations? Pain153(4) , 869–875 (2012).
- Spence D . Bad medicine: pain. BMJ340 , b5683 (2010).
▪ Websites
- Hippisley-Cox J, Vinogradova Y. Trends in consultation rates in general practice 1995 to 2008: analysis of the Q research® database. The NHS Information Centre for Health and Social Care. www.ic.nhs.uk/webfiles/publications/gp/Trends_in_Consultation_Rates_in_General_Practice_1995_2008.pdf (Accessed 4October2012)
- House of Commons Hansard written answers for 01 February 2012. www.publications.parliament.uk/pa/cm201212/cmhansrd/cm120201/text/120201w0002.htm (Accessed 4October2012)
- Pain Patient Pathway Working Group. www.britishpainsociety.org/members_articles_ppp.htm (Accessed 4October2012)